31 research outputs found
Global fecal and plasma metabolic dynamics related to Helicobacter pylori eradication
Background:Helicobacter pylori colonizes the gastric mucosa of more than half of the world's population. There is increasing evidence H. pylori protects against the development of obesity and childhood asthma/allergies in which the development of these diseases coincide with transient dysbiosis. However, the mechanism underlying the association of H. pylori eradication with human metabolic and immunological disorders is not well-established. In this study, we aimed to investigate the local and systemic effects of H. pylori eradication through untargeted fecal lipidomics and plasma metabolomics approaches by liquid chromatography mass spectrometry (LC-MS). Results: Our study revealed that eradication of H. pylori eradication (i.e., loss of H. pylori and/or H. pylori eradication therapy) changed many global metabolite/lipid features, with the majority being down-regulated. Our findings primarily show that H. pylori eradication affects the host energy and lipid metabolism which may eventually lead to the development of metabolic disorders. Conclusion: These predictive metabolic signatures of metabolic and immunological disorders following H. pylori eradication can provide insights into dynamic local and systemic metabolism related to H. pylori eradication in modulating human health
Helicobacter pylori eradication causes perturbation of the human gut microbiome in young adults
BACKGROUND: Accumulating evidence shows that Helicobacter pylori protects against some metabolic and immunological diseases in which the development of these diseases coincide with temporal or permanent dysbiosis. The aim of this study was to assess the effect of H. pylori eradication on the human gut microbiome. METHODS: As part of the currently on-going ESSAY (Eradication Study in Stable Adults/Youths) study, we collected stool samples from 17 H. pylori-positive young adult (18-30 years-old) volunteers. The same cohort was followed up 6, 12 and 18 months-post H. pylori eradication. The impact of H. pylori on the human gut microbiome pre- and post-eradication was investigated using high throughput 16S rRNA gene (V3-V4 region) sequencing using the Illumina Miseq followed by data analysis using Qiime pipeline. RESULTS: We compared the composition and diversity of bacterial communities in the fecal microbiome of the H. pylori-positive volunteers, before and after H. pylori eradication therapy. The 16S rRNA gene was sequenced at an average of 150,000-170,000 reads/sample. The microbial diversity were similar pre- and post-H. pylori eradication with no significant differences in richness and evenness of bacterial species. Despite that the general profile of the gut microbiome was similar pre- and post-eradication, some changes in the bacterial communities at the phylum and genus levels were notable, particularly the decrease in relative abundance of Bacterioidetes and corresponding increase in Firmicutes after H. pylori eradication. The significant increase of short-chain fatty acids (SCFA)-producing bacteria genera could also be associated with increased risk of metabolic disorders. CONCLUSIONS: Our preliminary stool metagenomics study shows that eradication of H. pylori caused perturbation of the gut microbiome and may indirectly affect the health of human. Clinicians should be aware of the effect of broad spectrum antibiotics used in H. pylori eradication regimen and be cautious in the clinical management of H. pylori infection, particularly in immunocompromised patients
Practical approach in hepatitis B e antigen-negative individuals to identify treatment candidates
Gastric Metastasis from Hepatocellular Carcinoma: A Rare Manifestation
[No abstract available
Understanding the underlying potential of listed property companies
Listed property companies are considered as another type of investment in the area of property investment in the global market. Therefore, listed property companies attract interest from a wide market globally. It has been observed that most of the previous researches have focused on risk adjusted return, diversification potential, optimal asset allocation and the dynamics of volatility of the investment whilst studying the performance of listed property companies. In addition, there have been some researches also conducted on the Malaysian listed property companies in the past. Hence, this paper attempts to provide a thorough understanding and knowledge of the listed property companies globally especially in Asia
The dynamic of linkages of Islamic REITs in mixed- asset portfolios in Malaysia
Islamic REIT (I-REITs) were introduced to the Malaysian stock market approximately ten years ago. This paper assesses dynamic linkages by using the Granger causality test of I-REITs. The study period is from 2008 to 2014. The study concentrates on comparisons between I-REITs and conventional REITs (C-REITs) and provides a better overview of comparisons and linkages of both asset classes. A Cointegration Test determined that a mixed-asset portfolio is cointegrated and shows less diversification benefits between the mixed-asset portfolios. The Granger causality test results has identified that industry portfolio can cause Granger I-REITs’ returns to change. This further confirms that I-REITs have good potential to diversify within any asset classes, including shares and bonds
Intergration of Islamic input in medical curriculum - Universiti Sains Islam Malaysia (USIM) experience
Muslim doctors are those qualified doctors who practise their professional knowledge and skills in line with Islam
and upholds the highest standards of ethical and professional behaviour. The medical curriculum of the Faculty
of Medicine and Health Sciences of Universiti Sains Islam Malaysia (USIM) was designed with the integration of
Islamic input which aims at producing doctors who are able to practise medicine that is integrated with Islamic,
moral and ethical values. Halaqah Studies and Fundamental Islamic Knowledge (FIK) courses such as History of
Medicine in Islam, Science and Medicine in Quran and Sunnah, Akhlak and Tasawuf, Islamic Jurisprudence and
Medical Ethics and Fiqh Issues are taught to students during the pre-clinical and clinical phases. Memorization of
selected Quranic verses throughout the programme aim to get the students to apply the verses of the al-Quran
into practice in everyday life and especially in their clinical practice. Islamic values are emphasised during
doctor-patient interactions in all clinical postings. Islamic knowledge and values integrated in the curriculum
are assessed in written and clinical examinations. The outcome of the integration of the Naqli component in the
medical curriculum has been demonstrated positively by the students in the patient management problems and
clinical consultations. Studies on the outcome of the integrated Islamic input in the medical curriculum among
the clinical students and graduates are being carried out
Optimizing first line 7‐day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
Objective: The 7-day standard triple therapy (STT) gives unacceptablly low eradication rates of Helicobacter pylori (H. pylori). We aimed to examine whether extending STT from 7 days to 14 days or adding a bismuth compound to a 7-day STT would result in better eradication rates. Methods: H. pylori-positive patients were assigned to Group A (7-day STT; rabeprazole 20 mg twice daily, amoxicillin 1 g twice daily, and clarithromycin 500 mg twice daily, for 7 days), Group B (7-day STT with bismuth; rabeprazole 20 mg twice daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily and bismuth subcitrate 240 mg twice daily, for 7 days) and Group C (14-day STT; rabeprazole 20 mg twice daily, amoxicillin 1 g twice daily, and clarithromycin 500 mg twice daily for 14 days). Eradication was tested using 13 C-UBT at least 4 weeks after the completion of therapy. Results: A total of 364 patients were recruited. In the intention-to-treat analysis, eradication rates were 79.3% (96/121; 95% confidence interval [CI] 71.3–85.6%) for 7-day STT, 81.7% (98/120; 95% CI 73.8–87.6%) for 7-day STT with bismuth, and 88.6% (109/123; 95% CI 81.8–93.1%) for 14-day STT, respectively. Statistical significance was achieved between the 7-day and the 14-day STT treatment (P = 0.048). Conclusions: Adding bismuth to the 7-day STT did not result in an increase in the eradication rate. Extending the STT to 14 days, however, achieved a significantly higher eradication rate. Nevertheless, this did not achieve the targeted 90% eradication rate on intention-to-treat analysis